ロード中...

Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants

BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are the class of antiretroviral (ARV) drugs most recently approved by the FDA for the treatment of HIV-1 infections. INSTIs block the strand transfer reaction catalyzed by HIV-1 integrase (IN) and have been shown to potently inhibit infection...

詳細記述

保存先:
書誌詳細
出版年:Retrovirology
主要な著者: Smith, Steven J., Zhao, Xue Zhi, Burke, Terrence R., Hughes, Stephen H.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956922/
https://ncbi.nlm.nih.gov/pubmed/29769116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-018-0420-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!